CIK: 1132679 - Address: 1111 Lincoln Road,, Suite 500, Miami Beach, FL 33139
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1120-4-7-6-5322
S%wins100100100100505083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/19/23 20:24
12/19/23
BCABBioatla, Inc.DEHealthBioPrdBiological Products, (No DiagSteinman LawrenceCADP412.0502010838D
6/6/23 21:00
6/2/23
KTTAPasithea Therapeutics Corp.DEHealthDrugPharmaceutical PreparationsSteinman LawrenceFLDP130.431003021,327D
6/2/23 08:00
6/1/23
ATNF180 Life Sciences Corp.DEHealthDrugPharmaceutical PreparationsSteinman LawrenceCADP221.230186048D
12/10/21 08:22
12/9/21
ATNF180 Life Sciences Corp.DEHealthDrugPharmaceutical PreparationsSteinman LawrenceCADP.d214.27051603D
11/3/21 17:09
11/2/21
BCABBioatla, Inc.DEHealthBioPrdBiological Products, (No DiagSteinman LawrenceCADS-1430.0000-218D
9/17/21 14:05
9/15/21
BCABBioatla, Inc.DEHealthBioPrdBiological Products, (No DiagSteinman LawrenceCADS-1736.8200-219D
8/18/21 17:48
8/16/21
BCABBioatla, Inc.DEHealthBioPrdBiological Products, (No DiagSteinman LawrenceCADS-1840.6000-219D
7/19/21 21:25
7/15/21
BCABBioatla, Inc.DEHealthBioPrdBiological Products, (No DiagSteinman LawrenceCADS-1738.2900-220D
3/2/05 14:24
3/2/05
NBIXNeurocrine Biosciences IncCAHealthBioPrdBiological Products, (No DiagSteinman LawrenceCADS-16441.1025-4-2116D-4-27-18-13-11-5-110-3-6-71366
9/17/04 15:53
9/15/04
NBIXNeurocrine Biosciences IncCAHealthBioPrdBiological Products, (No DiagSteinman LawrenceCADS-10150.2521-2-920D33-5-13-22150-10-4-8-4-23-2

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact